CAS 2070009-58-2

GDC-0994 hydrochloride

CAS : 2070009-58-2

GDC-0994 hydrochloride

Masse moléculaire : 477.32g/mol

Ref: 54-BISN0287

Ravoxertinib hydrochloride

CAS : 2070009-58-2

Ravoxertinib hydrochloride is an investigational pharmaceutical compound, specifically a selective small molecule inhibitor. It is synthesized chemically, designed to target and inhibit specific protein kinases, particularly those associated with the ERK signaling pathway. The mode of action involves binding to these kinases, thus preventing their phosphorylation and subsequent activation. This interruption of the cellular signaling cascade can result in the suppression of tumor cell proliferation and survival.

Formule : C₂₁H₁₉Cl₂FN₆O₂

Degré de pureté : Min. 95%

Masse moléculaire : 477.3 g/mol

Ref: 3D-VHD00958

Ravoxertinib hydrochloride

CAS : 2070009-58-2

Ravoxertinib hydrochloride is an orally bioavailable and selective inhibitor for ERK kinase activity (IC50: 6.1 nM and 3.1 nM for ERK1 and ERK2, respectively).

Formule : C₂₁H₁₉Cl₂FN₆O₂

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 477.32

Ref: TM-T15377